• IJMPO
image
Welcome,
Change Password

Role of Immunotherapy in 1st line unresectable recurrent or Metastatic Head & Neck squamous cell carcinoma

Role of Immunotherapy in 1st line unresectable recurrent or Metastatic Head & Neck squamous cell carcinoma

Dr. Aditya Murli

Watch Video

Case of Metastatic NSCLC

Case of Metastatic NSCLC

Lead Discussant: Dr. Sajjan Rajpurohit, Dr. Rashmi Bansal

Watch Video

Case of Metastatic RCC

Case of Metastatic RCC

Lead Discussant: Dr. Chandan k Das, Dr. Jatin Chaudhari

Watch Video

Case of Metastatic Colorectal Cancer

Case of Metastatic Colorectal Cancer

Lead Discussant: Dr. Viraj Lavingia 

Watch Video

Case of Metastatic Ovarian Cancer

Case of Metastatic Ovarian Cancer

Lead Discussant: Dr. Anita Ramesh

Watch Video

Experience Sharing on Durvalumab in ES-SCLC

Experience Sharing on Durvalumab  in ES-SCLC

Dr. Chintan Shah

Watch Video

Real world Evidence Osimertinib as SoC in the management of EGFRm NSCLC

Real world Evidence Osimertinib as SoC in the management of EGFRm NSCLC

Dr. Amit Rauthan

Watch Video

Deep dive into clinical practice of unresectable HCC: Managing Patients with Atezolizumab Bevacizumab combination in Unresectable HCC

Deep dive into clinical practice of unresectable HCC: Managing Patients with Atezolizumab Bevacizumab combination in Unresectable HCC

Moderator: Dr. Ashish Joshi

Watch Video

Do novel systemic approaches reset the clock for treatment selection and sequencing in mCRC

Do novel systemic approaches reset the clock for treatment selection and sequencing in mCRC

Dr. Dipanjan Panda

Watch Video

Pushing the boundaries optimising survival with new strategies in HER2 +ve and negative disease

Pushing the boundaries optimising survival with new strategies in HER2 +ve and negative disease

Dr. Krishna Prasad

Watch Video

New development in the therapeutic game plan for treatment of HCC

New development in the therapeutic game plan for treatment of HCC

Dr. M. Vamshi Krishna

Watch Video

panel discussion (mCRC/GeJ/Gastric Cancer): real world perspective "Implementing state of the art in the clinic"

panel discussion (mCRC/GeJ/Gastric Cancer): real world perspective "Implementing state of the art in the clinic"

Moderator : Dr. Anant Ramaswamy

Watch Video

Sequencing therapies in metastatic castration sensitive and resistant prostate cancer: Impact of new evidence and predictive markers

Sequencing therapies in metastatic castration sensitive and resistant prostate cancer: Impact of new evidence and predictive markers

Dr. Chirag Desai

Watch Video

New algorithms of treatment of mRCC in 1st and subsequent lines

New algorithms of treatment of mRCC in 1st and subsequent lines

Dr. T. Raja

Watch Video

Embarking on novel stratgeies on metastatic Bladder cancer : putting chemotherapy on the backburner

Embarking on novel stratgeies on metastatic Bladder cancer : putting chemotherapy on the backburner

Dr. Bharat Vaswani

Watch Video

Panel discussion (GU cancers ): Real world perspective” implementing state of art in the clinic"

Panel discussion (GU cancers ): Real world perspective” implementing state of art in the clinic"

Moderator: Dr. Chirag Desai

Watch Video

Ovarian cancer : Personalised Medicine in Incorporating Novel Therapies Today and Tommorrow

Ovarian cancer : Personalised Medicine in Incorporating Novel Therapies Today and Tommorrow

Dr. Amit Agarwal

Watch Video

Endometrial Cancer: “Changing the Guard with Targeted Systemic Options and Immunotherapy”.

Endometrial Cancer: “Changing the Guard with Targeted Systemic Options and Immunotherapy”.

Dr. Susana Banerjee

Watch Video

Cervical Cancer: What has changed now and what lies on the horizon

Cervical Cancer: What has changed now and what lies on the horizon

Dr. Sudeep Gupta

Watch Video

Panel Discussion (Gynecological Cancers): Real World Perspective” How Do I Treat”

Panel Discussion (Gynecological Cancers): Real World Perspective” How Do I Treat”

Moderator: Dr. Chanchal Goswami

Watch Video

Journey of A medical oncology in India- Opportunities Galore

Journey of  A medical oncology in India- Opportunities Galore

Dr. Shyam Aggarwal

Watch Video

Advancing Equitable Cancer Care Through Innovation

Advancing Equitable Cancer Care Through Innovation

Dr. Everett Vokes

Watch Video

Our problems our solutions

Our  problems our solutions

Dr. Govind Babu

Watch Video

Cancer does not take a day off then why should a CDK 4/6 inhibitor?

Cancer does not take a day off then why should a CDK 4/6 inhibitor?

Dr. Shyam Aggarwal

Watch Video

Clinical Case presentation - Why I chose Abemaciclib for my HR+/HER2- MBC patient with Poor Prognostic Factors

Clinical Case presentation - Why I chose Abemaciclib for my HR+/HER2- MBC patient with Poor Prognostic Factors

Dr. Bharat Vaswani

Watch Video

Redefining Overall Survival

Redefining Overall Survival

Dr. Akhil Kapoor

Watch Video

Panel Discussion

Panel Discussion

Moderator: Dr. MVT Krishna Mohan

Watch Video